---
schema_version: "secwatch.filing_event.v1"
accession: "0001516551-21-000015"
form_type: "8-K"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2021-10-06T23:59:59+00:00"
generated_at: "2026-06-28T22:34:48.441544+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience appoints Kaitlyn Arsenault as CFO, replacing interim Principal Accounting Officer

## Summary
- Punit Dhillon resigned as interim Principal Accounting Officer effective Oct 4, 2021; Kaitlyn Arsenault appointed CFO immediately.
- Arsenault receives options for 1.6M shares at $0.09; 10% vest immediately, remainder over 4 years semi-annually.
- Annual base salary $300k with discretionary bonus up to 35% of base; severance of 6 months' salary if terminated not for cause.
- Arsenault has 14+ years experience in life science accounting, previously consultant to Skye for 6 years and Assurance Manager at Friedman LLP.
- Skye is a biopharma developing cannabinoid-derived molecules for unmet medical needs; CFO appointment supports clinical program advancement.

## SEC filing metadata
- accession: 0001516551-21-000015
- form_type: 8-K
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2021-10-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000151655121000015/0001516551-21-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000151655121000015/skye-20211005.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516551-21-000015
- JSON: https://secwatch.observer/filing/0001516551-21-000015.json
- Plain text: https://secwatch.observer/filing/0001516551-21-000015.txt

## Key facts
- Executive change
  Punit Dhillon resigned as interim Principal Accounting Officer at Skye Bioscience, Inc..
  - Action: resigned
  - Role: interim Principal Accounting Officer
  source text: As of October 4, 2021, Punit Dhillon has tendered his resignation from his position as the interim Principal Accounting Officer of Skye Bioscience, Inc. (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655121000015/0001516551-21-000015-index.htm
- Executive change
  Kaitlyn Arsenault was appointed as Chief Financial Officer at Skye Bioscience, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On October 4, 2021, the Board of Directors of the Company (the “Board”) appointed Kaitlyn Arsenault as the new Chief Financial Officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655121000015/0001516551-21-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.